Publications by authors named "Raju Mohan"

Claim this Profile
A
A Walk across Europe: Development of a high-resolution walkability index.
Nishit Patel, Hoang-Ha Nguyen, Jet van de Geest, Alfred Wagtendonk, Mohan J S Raju

Health Place· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Socioeconomic and sex disparities in hypertension and diabetes mellitus care cascade among tribal populations in Odisha, India: findings from the Odisha Tribal Family Health Survey (OTFHS), 2022-23.
Tanveer Rehman, Chinmayee Sethy, Afeeq K, Jaya Singh Kshatri, Manikandanesan Sakthivel, Mohan Kumar Raju

BMC Public Health· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Problematic Internet Use Among Adolescent School Attendees: A School-based Study from Tamil Nadu, India.
Lakshmi Shanthi, Jeyashree Ashwath, Mohan Kumar Raju, Sudha Ramalingam

Indian Pediatr· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxygen Scarcity and COVID-19: Lessons Learned During the May-June 2021 Peak, Karnataka, India.
Prashanth Bhat, Mohan Kumar Raju, Veenita Anand, Shashikiran Umakanth, K Ravikumar

Indian J Public Health· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for establishing a model for integrated influenza surveillance in Tamil Nadu, India.
Rizwan S Abdulkader, Varsha Potdar, Gulam Mohd, Joshua Chadwick, Mohan Kumar Raju

Front Public Health· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'Kyasanur Forest Disease, is our surveillance system healthy to prevent a larger outbreak? A mixed-method study, Shivamogga, Karnataka, India: 2019'International Journal of Infectious Diseases, Volume 110S1, October 2021, Pages S50-S61.
Prashant Bhat, Jagadeesha H S, Mohan Kumar Raju, Sudheerchandra Sooda, Premanand K

Int J Infect Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profile of clinical trials registered as a medical postgraduate research thesis, 2007 to 2019: Lessons for capacity building.
Janana Priya Gunasekaran, Raginee Dongre, Sri Madhupriya Mahendiran, Mohan Kumar Raju, Manickam Ponnaiah

Perspect Clin Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022.
Mohan Kumar Raju, Jeromie Wesley Vivian Thangaraj, T S Selvavinayagam, A Somasundaram, K Parthipan

Indian J Med Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kyasanur Forest Disease, is our surveillance system healthy to prevent a larger outbreak? A mixed-method study, Shivamogga, Karnataka, India: 2019.
Prashant Bhat, Jagadeesha H S, Mohan Kumar Raju, Sudheerchandra Sooda, Premanand K

Int J Infect Dis· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversible, orally available ADP receptor (P2Y) antagonists Part I: Hit to lead process.
Imadul Islam, Shendong Yuan, Robert G Wei, Wei Xu, Michael Morrissey, Raju Mohan

Bioorg Med Chem Lett· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Highly Potent Liver X Receptor β Agonists.
Ellen K Kick, Brett B Busch, Richard Martin, William C Stevens, Venkataiah Bollu, Raju Mohan

ACS Med Chem Lett· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beneficial and Adverse Effects of an LXR Agonist on Human Lipid and Lipoprotein Metabolism and Circulating Neutrophils.
Todd G Kirchgessner, Paul Sleph, Jacek Ostrowski, John Lupisella, Carol S Ryan, Raju Mohan

Cell Metab· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of 'accredited social health activists'-a national community health volunteer scheme in Karnataka State, India.
Farah N Fathima, Mohan Raju, Kiruba S Varadharajan, Aditi Krishnamurthy, S R Ananthkumar

J Health Popul Nutr· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological characterization of a novel liver X receptor agonist with partial LXRα activity and a favorable window in nonhuman primates.
Todd G Kirchgessner, Richard Martin, Paul Sleph, Denise Grimm, Xiaoqin Liu, Raju Mohan

J Pharmacol Exp Ther· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver X receptor (LXR) partial agonists: biaryl pyrazoles and imidazoles displaying a preference for LXRβ.
Ellen Kick, Richard Martin, Yinong Xie, Brenton Flatt, Edwin Schweiger, Raju Mohan

Bioorg Med Chem Lett· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of personality dimensions and aggression in romantic relationship among youth.
Manoj K Sharma, Mohan Raju

Indian J Psychol Med· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and characterization of an inhibitor of glucosylceramide synthase.
Steven Richards, Christopher J Larson, Elena S Koltun, Art Hanel, Vicky Chan, Raju Mohan

J Med Chem· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a new class of glucosylceramide synthase inhibitors.
Elena Koltun, Steven Richards, Vicky Chan, Jason Nachtigall, Hongwang Du, Raju Mohan

Bioorg Med Chem Lett· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Test Anxiety Scale: reliability among Ethiopian students.
P Mohan Raju, Misganaw Mesfin, Esa Alia

Psychol Rep· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Death anxiety among Ethiopian undergraduate students.
P Mohan Raju

Psychol Rep· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of XL335 (WAY-362450), a highly potent, selective, and orally active agonist of the farnesoid X receptor (FXR).
Brenton Flatt, Richard Martin, Tie-Lin Wang, Paige Mahaney, Brett Murphy, Raju Mohan

J Med Chem· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1-(1,3-Benzodioxol-5-ylmethyl)-3-[4-(1H-imidazol-1-yl)phenoxy]-piperidine analogs as potent and selective inhibitors of nitric oxide formation.
Robert G Wei, Marc Adler, David Davey, Elena Ho, Raju Mohan

Bioorg Med Chem Lett· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3-Mercaptopropionic acids as efficacious inhibitors of activated thrombin activatable fibrinolysis inhibitor (TAFIa).
Imadul Islam, Judi Bryant, Karen May, Raju Mohan, Shendong Yuan

Bioorg Med Chem Lett· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attitude towards euthanasia in relation to death anxiety among a sample of 343 nurses in India.
Ratna Ray, Mohan Raju

Psychol Rep· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crystal structures of potent thiol-based inhibitors bound to carboxypeptidase B.
Marc Adler, Judi Bryant, Brad Buckman, Imadul Islam, Brent Larsen, Raju Mohan

Biochemistry· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis